Baer Investment Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
3,240
+124
+4% +$59.5K 1.39% 27
2026
Q1
$1.53M Buy
3,116
+93
+3% +$50.5K 1.53% 24
2025
Q4
$1.75M Buy
3,023
+13
+0.4% +$7.35K 1.67% 25
2025
Q3
$1.46M Sell
3,010
-478
-14% -$222K 1.25% 28
2025
Q2
$1.38M Sell
3,488
-125
-3% -$52.3K 1.57% 26
2025
Q1
$2.11M Buy
3,613
+2,077
+135% +$1.12M 2.73% 20
2024
Q4
$1.09M Buy
+1,536
New +$844K 1.18% 22

Other funds holding TMO

Baer Investment Advisory's TMO Position: Q2 2026 in Review

Baer Investment Advisory increased its Thermo Fisher Scientific (TMO) stake by 4% in Q2 2026, buying an estimated $59.5K and bringing the position to 3,240 shares worth $1.66M. The position accounts for 1.39% of the portfolio, ranked #27.

Baer Investment Advisory first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.11M in Q1 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Baer Investment Advisory held 3,240 shares of Thermo Fisher Scientific worth $1.66M as of Q2 2026.
  • Baer Investment Advisory bought 124 Thermo Fisher Scientific shares in Q2 2026, an estimated $59.5K.
  • Thermo Fisher Scientific made up 1.39% of Baer Investment Advisory's portfolio in Q2 2026, its #27 holding.
  • Baer Investment Advisory first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Baer Investment Advisory's Thermo Fisher Scientific position peaked at $2.11M in Q1 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Baer Investment Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.